医学
炎症性肠病
神经炎症
丁酸梭菌
肠神经系统
结肠炎
炎症
肠易激综合征
疾病
免疫学
肠粘膜
肠道通透性
输送系统
乙酰胆碱
溃疡性结肠炎
炎症性肠病
生物信息学
基因传递
治疗方法
神经科学
神经免疫学
胃肠系统
微生物群
中枢神经系统
克罗恩病
全身给药
巨噬细胞
细胞因子
内科学
作者
Xinxin Liu,Luo Zhao,Liulu Wu,Yangyang Zhang,Yange Du,Ziqing Wang,Mengya Niu,Cuixia Zheng,Hongmin Liu,Lei Wang
标识
DOI:10.1186/s12951-026-04850-z
摘要
With the emergence of the gut-brain axis, inflammatory bowel disease (IBD) is no longer simply regarded as a localized intestinal disease but as a systemic disorder intimately associated with psychiatric comorbidities, including anxiety and depression. However, conventional therapeutic strategies predominantly target localized colonic inflammation, which often yields suboptimal outcomes. This highlights a critical need for gut-brain co-therapy to achieve comprehensive IBD management. Based on our observation that indole-3-acetic acid (IAA) possesses the potential to attenuate hippocampal neuroinflammation and subsequently modulate intestinal inflammation via the acetylcholine pathway, we engineered a gut-brain co-therapy delivery platform (CB-ASA/IAA/L). This system comprises Clostridium butyricum (CB) loaded with 5-aminosalicylic acid (5-ASA), encapsulated by a pH-responsive Eudragit L100-55 layer incorporating IAA. This microecological preparation is based on effective protection and delivery of CB, achieving the delivery of IAA to the brain and 5-ASA to the colon simultaneously. This sequential-release delivery system achieved intestinal barrier repair, promoted macrophage polarization toward the M2 phenotype, and restored Th17/Treg balance to recover intestinal homeostasis, while simultaneously alleviating anxiety- and depression-like behaviors in colitis mice. Importantly, the system demonstrated a robust ability to prevent inflammatory recurrence, a major clinical challenge in IBD treatment. This research offers a new avenue for the effective treatment of IBD-associated anxiety/depression by coordinating neuroimmune modulation with local intestinal repair. Schematic illustration of the synthesis, site-specific gastrointestinal delivery, and gut–brain axis-mediated therapeutic mechanisms of CB-ASA/IAA/L against inflammatory bowel disease and associated anxiety/depression.
科研通智能强力驱动
Strongly Powered by AbleSci AI